Skip to main content

Table 3 Accuracy of the different thresholds SSEP, EEG benign patterns, no myoclonus, NSE peak at day 3 < 60 µg/ml, and combinations for prediction of good outcome

From: SSEP N20 and P25 amplitudes predict poor and good neurologic outcomes after cardiac arrest

  Se(%) Sp(%) FPR(%)
N20-baseline > 2 µV 39 (33–44) 73 (68–78) 27 (22–32)
N20-baseline > 2.7 µV 28 (23–33) 87 (83–91) 13 (9–17)
N20–P25 > 3,2 µV 29 (23–34) 93 (90–96) 7 (4–10)
N20–P25 > 4 µV 14 (10–18) 95 (92–97) 5.4 (3–8)
No status myoclonus 94 (92–97) 56 (51–62) 44 (38–49)
Day 3 NSE peak < 60 µg/ml 93 (90–96) 74.5 (69–80) 25.5 (20–31)
Benign EEG 89 (85–92) 86 (82–90) 14 (10–18)
N20-baseline > 2 µV + benign EEG 33.3 (28–39) 96.9 (95–99) 3.1 (1–5)
N20-baseline > 2 µV + NSE < 60 ng/ml 28 (23–33) 90.6 (87–94) 9.4 (6–13)
N20-baseline > 2 µV + no status myoclonus 33.3 (28–39) 86 (82–90) 14 (10–18)
N20–P25 > 3.2 µV + benign EEG 17 (13–21) 97 (93–98) 3 (2–7)
N20–P25 > 3.2 µV + day 3 NSE < 60 µg/ml 17 (13–21) 98.4 (97–100) 1.6 (0–3)
N20–P25 > 3.2 µV + No status myoclonus 17 (13–21) 95.3 (93–98) 4.7 (2–7)